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Over the past two decades, components of the vertebrate 
visual transduction cascade have been characterized, and 
their functions in light-regulated signaling are well estab-
lished. Visual signaling in the mouse retina does not begin 
until postnatal day (P) 13–14 [1]. Correspondingly, the onset 
of expression for rhodopsin and the cone opsins precedes 
eye opening and visual signaling by several days. However, 
rod and cone histogenesis begins even earlier, occurring in 
two distinct phases in vertebrate retinogenesis, with cones 
born embryonically and rods formed primarily during late 
embryogenesis and the postnatal period in rodents [2,3].
One of the mysteries of vertebrate retinogenesis is the 
lag between cone histogenesis and cone opsin expression. A 
similar lag exists between rod histogenesis and rhodopsin 
expression, although the delay is not as extended and occurs 
postnatally [4]. In mouse cone development, the earliest cones 
become postmitotic around embryonic day (E)11.5 while 
cone opsin transcription starts days later, with S-cone opsin 
mRNA expressed by E15.5 [5,6] followed by faint mRNA 
expression for M-cone opsin around P7 [6,7]. Cone histogen-
esis and cone opsin protein expression shows an even greater 
lag, with S-cone opsin protein expression detected at P0 [5], 
and M-cone opsin protein expression detected around P14 
[8,9].
Several genes involved in photoreceptor fate specifica-
tion and differentiation are expressed during early cone 
histogenesis, including Otx2, NeuroD, Blimp1, Rorβ, and Crx 
[10-17], but these factors are all expressed in rods and cones. 
Early determinants of cone differentiation include Rxrγ and 
Trβ2, although again these factors are thought to regulate 
cone cell fate [5,18-20]. Alternatively, proteins involved in 
visual transduction (potential markers of differentiated cones) 
are expressed at or slightly preceding the onset of cone opsin 
expression, which is still days before the onset of visual 
transduction. However, one cone marker involved in visual 
transduction is expressed embryonically; cone transducin γ 
expression was detected at E15.5 in mice [21].
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Purpose: Photoreceptor cells are born in two distinct phases of vertebrate retinogenesis. In the mouse retina, cones 
are born primarily during embryogenesis, while rod formation occurs later in embryogenesis and early postnatal ages. 
Despite this dichotomy in photoreceptor birthdates, the visual pigments and phototransduction machinery are not reac-
tive to visual stimulus in either type of photoreceptor cell until the second postnatal week. Several markers of early 
cone formation have been identified, including Otx2, Crx, Blimp1, NeuroD, Trβ2, Rorβ, and Rxrγ, and all are thought 
to be involved in cellular determination. However, little is known about the expression of proteins involved in cone 
visual transduction during early retinogenesis. Therefore, we sought to characterize visual transduction proteins that 
are expressed specifically in photoreceptors during mouse embryogenesis.
Methods: Eye tissue was collected from control and phosducin-null mice at embryonic and early postnatal ages. Im-
munohistochemistry and quantitative reverse transcriptase-PCR (qPCR) were used to measure the spatial and temporal 
expression patterns of phosducin (Pdc) and cone transducin γ (Gngt2) proteins and transcripts in the embryonic and 
early postnatal mouse retina.
Results: We identified the embryonic expression of phosducin (Pdc) and cone transducin γ (Gngt2) that coincides tem-
porally and spatially with the earliest stages of cone histogenesis. Using immunohistochemistry, the phosducin protein 
was first detected in the retina at embryonic day (E)12.5, and cone transducin γ was observed at E13.5. The phosducin and 
cone transducin γ proteins were seen only in the outer neuroblastic layer, consistent with their expression in photorecep-
tors. At the embryonic ages, phosducin was coexpressed with Rxrγ, a known cone marker, and with Otx2, a marker of 
photoreceptors. Pdc and Gngt2 mRNAs were detected as early as E10.5 with qPCR, although at low levels.
Conclusions: Visual transduction proteins are expressed at the earliest stages in developing cones, well before the onset 
of opsin gene expression. Given the delay in opsin expression in rods and cones, we speculate on the embryonic function 
of these G-protein signaling components beyond their roles in the visual transduction cascade.
Correspondence to: Peter H. Mathers, PO Box 9303, Sensory 
Neuroscience Research Center West Virginia University, 
Morgantown, WV 26506-9303; Phone: (304) 293 0271; FAX: (304) 
293-7182; email: pmathers@hsc.wvu.edu
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Transducin is a heterotrimeric G protein found in rod 
and cone photoreceptors. Transducin is composed of three 
subunits, designated as Gαt1β1γ1 and Gαt2β3γ8 in rods and 
cones, respectively. The genes encoding the transducin 
subunits in cones are Gnat2, Gnbt2, and Gngt2. Transducin 
is an essential component of the phototransduction cascade. 
When photons are absorbed by either rhodopsin or cone opsin, 
transducin is activated. Once activated, transducin separates 
into α- and βγ-subunits. The α-subunit subsequently activates 
phosphodiesterase 6, which, in turn, reduces the intracellular 
cGMP levels and leads to hyperpolarization. The βγ-subunit 
forms a complex with phosducin, a cytosolic phosphoprotein 
expressed in rods and cones [22-27]. Phosducin is involved 
in the translocation of transducin βγ within photoreceptors 
during light adaptation [28].
We sought to characterize the expression of visual trans-
duction proteins that are active embryonically during cone 
histogenesis. We report that phosducin and cone transducin 
γ are expressed early in cone histogenesis, with phosducin 
expression detected at E12.5 and cone transducin γ at 
E13.5. Here, we show the spatial and temporal profiles for 
the expression of these two genes and their corresponding 
proteins during the embryonic and postnatal periods.
METHODS
Animals and tissue collection: Embryonic and postnatal 
eyes were collected from time-pregnant FVB/N female mice 
that had been mated with C57Bl/6J male mice to prevent the 
retinal degeneration (rd1/rd1) present in the FVB/N strain 
[29-31]. Eyes from mice at the selected ages (E13.5 and P0) 
were also collected from pure C57Bl/6J mice (to test for strain 
differences) and from a phosducin-null strain [28] (to test for 
antibody and primer specificity). Midnight of the mating 
date was considered embryonic day (E)0. The day of birth 
was counted as postnatal day (P)0. For mouse pups E10.5-
E17.5, the mother was euthanized by cervical dislocation, 
fetuses were then surgically dissected from the uterus and 
decapitated. Newborn mouse pups (P0) were euthanized via 
decapitation following induced hypothermia and P21 pups 
were euthanized by cervical dislocation followed by decapita-
tion. Following euthanasia, whole eyes were removed from 
the orbit using either a 26g beveled needle (E10.5–E13.5) or 
forceps (E15.5–P21). Eyes for immunohistology were fixed 
as whole heads (E10.5–17.5) or just eyes (P0–P21) in a 4% 
paraformaldehyde solution of phosphate-buffered saline (1X 
PBS; 150 mM NaCl, 1.06 mM KH2PO4, 2.97 mM Na2HPO4-
7H2O, pH 7.4) at 4 °C overnight, and cryoprotected in 30% 
sucrose, 1X PBS. The eyes for the quantitative reverse 
transcriptase–PCR (qPCR) analysis were frozen on dry ice 
in pairs. All animal procedures were approved by the West 
Virginia University (WVU) Institutional Animal Care and 
Use Committee and followed the guidelines set out by the 
Association for Research in Vision and Ophthalmology.
Immunohistochemistry and immunofluorescence: Cryopro-
tected eyes (n = 6 for each age) were mounted in TBS tissue 
freezing media (Triangle Biomedical Sciences, Durham, NC), 
frozen and sectioned on a Leica CM3050S cryostat (Buffalo 
Grove, IL) at 10 μm thickness, and then transferred to glass 
slides. Before the antibody processing, as part of our standard 
protocol, the samples were subjected to an antigen retrieval 
procedure of 0.1 M Tris pH 9.5 incubation at 95 °C for 20 min. 
Test runs with and without antigen retrieval showed similar 
labeling for the phosducin and cone transducin γ antibodies. 
Following antigen retrieval, the sections were blocked with 
normal serum and treated with primary and secondary anti-
bodies, following our published procedure [32]. The primary 
antibodies used in this study were anti-phosducin (as previ-
ously described by Sokolov et al. [28]; 1:1,000), anti-cone 
transducin γ (rabbit; CytoSignal, Irvine, CA; 1:500–1,000), 
anti-S cone opsin (rabbit; Chemicon, Temecula, CA; 1:100), 
anti-mouse cone arrestin (mouse; gift from Dr. Cheryl Craft; 
1:500), anti-retinoid X receptor γ (rabbit; Santa Cruz Biotech-
nology, Dallas, TX; 1:1000), anti-cone phosphodiesterase 
(rabbit; Thermo Fisher Scientific, Waltham, MA; 1:500), 
and anti-Otx2 (rabbit; Millipore, Billerica, MA; 1:1000). 
Secondary antibodies were anti-sheep, anti-mouse, or anti-
rabbit antibodies that were either biotin-labeled for Elite-
ABC reactions (Vector Laboratories Inc.; Burlingame, CA) 
or fluorophore-tagged for immunofluorescence (Molecular 
Probes, Eugene, OR). Images were captured on an Olympus 
AX70 microscope (Olympus; Center Valley, PA) equipped 
with a MicroFire digital camera (Optronics; Goleta, CA) or a 
Zeiss 710 confocal microscope (Carl Zeiss, Inc.; Thornwood, 
NY).
Quantification of colabeled cells: Eyes from E13.5, E15.5, 
E17.5, and P0 mouse pups were sectioned at 12 μm thick-
ness. Immunofluorescence following the above protocol was 
performed on the retinal sections using anti-phosducin and 
anti-cone transducin γ antibodies and propidium iodide as a 
nuclear counterstain. Three animals per age, with multiple 
quadrants of at least three sections per animal, were imaged 
on a Zeiss 710 confocal microscope. Labeled cells were 
counted within the imaged Z-stacks using the cell counter 
plugin of Fiji imaging software (Madison, WI) [33]. All 
labeled cells were counted and designated as colabeled, 
phosducin only, or cone transducin γ only. The percentage 
of labeled cells was then calculated by dividing the number 
of cells in each category by the total number of labeled cells 
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for each age. Data are presented as percentage ± standard 
deviation (SD) for each category.
Quantitative reverse transcriptase–PCR: Total RNA was 
isolated from pairs of eyes from three mice at each age 
according to the manufacturer’s instructions using either 
the Absolutely RNA Miniprep kit (Agilent Technologies, 
Inc.; Santa Clara, CA) with modifications for small samples 
for E13.5–P8 or the Absolutely RNA Nanoprep kit (Agilent 
Technologies) for E10.5–12.5. Each RNA sample was double 
DNase-treated, and the RNA concentration was quantified 
with a Nanodrop ND-1000 spectrophotometer (Thermo 
Scientific; West Palm Beach, FL). Select RNA samples were 
also analyzed on Bioanalyzer chips (Agilent Technologies). 
Fifty nanograms of total RNA were reverse transcribed 
using oligo(dT) primers and the AffinityScript QPCR cDNA 
Synthesis kit (Agilent Technologies), and cDNA samples 
originating from the same animals were pooled. Primers were 
designed using GenBank mouse mRNA sequences so that the 
amplimer would cover an exon–exon boundary. The following 
primer sequences were synthesized and high-performance 
liquid chromatography (HPLC)–purified by Integrated DNA 
Technologies (IDT; Coralville, IA); phosducin (Pdc; 5′-GCA 
CAC AGG ACC CAA AGG AGT AAT-3′ and 5′-ACA 
CAA ACC CAT ACC TAG GCC CAA-3′), cone transducin 
γ (Gngt2; 5′-GGA AGT GAA GAA CCC ACG TGA TCT 
GA-3′ and 5′-AGC ACA CAA GTG CCT TTC TCC TTG-3′), 
and hypoxanthine-guanine phosphoribosyltransferase (Hprt; 
5′-CAG GCC AGA CTT TGT TGG AT-3′ and 5′- GGA CGC 
AGC AAC TGA CAT T-3′). Before beginning, the primer 
concentrations were optimized for each forward and reverse 
primer. The qPCR reaction efficiencies for each pair were 
confirmed to be within a range of 90–110%. Reactions 
were prepared in technical triplicate using Brilliant SYBR 
Green QPCR Master Mix (Agilent Technologies), including 
reference dye, and 5 ng of each cDNA with 100 nM of each 
forward and reverse primer. Reactions were incubated at 
95 °C for 10 min and then cycled at 95 °C for 30 s, 55 °C for 
60 s, and 72 °C for 60 s using a Stratagene (San Diego, CA) 
Mx3000P real-time PCR system. A melting curve analysis 
was added at the end to verify a single product from each 
reaction, and the fluorescence was recorded during every 
PCR cycle at the annealing step (55 °C) and the extension 
step (72 °C). Finally, select PCR products were also verified 
by size on agarose gels to ensure single band amplifications. 
The final relative quantities of Pdc and Gngt2 expression 
were determined after normalization to Hprt by the MxPro™ 
QPCR software version 3.00 (Stratagene). In addition, three 
reference P0 samples were run in triplicate on every plate 
so that interplate variations could be controlled. As a result, 
the data presented are also normalized to the P0 expression 
levels.
RESULTS
Expression of phosducin in the developing mouse retina: 
Phosducin (Pdc) expression is known to be specific to 
photoreceptors in the retina, with expression found in rods 
and cones [24,26]. Previous studies have shown phosducin 
expression primarily in the early postnatal and adult retina 
[27,34,35], but the expression of phosducin during embryo-
genesis has not been explored. Using a well-characterized 
sheep antibody against phosducin [28,36,37], we identified 
phosducin expression in sections of embryonic mouse retina 
(Figure 1). This prompted us to perform a developmental 
series of phosducin expression, covering the earliest stages of 
mouse retinogenesis (E10.5) until after the maturation of rod 
photoreceptors (P21, Figure 1I). No phosducin protein expres-
sion was detectable at E10.5 or E11.5 (Figure 1A,B). Starting 
at E12.5, a small number of cells expressing phosducin 
protein were present in the central retina (arrows in Figure 
1C). Most reactive cells were present in the outer neuroblastic 
layer (Figure 1D). This location is consistent with the posi-
tion of the future outer nuclear layer, where differentiated 
photoreceptors will reside. Given the ventricular location of 
these phosducin-positive cells and the reported expression 
specificity of phosducin [24,26], the labeled cells likely repre-
sent photoreceptors that have either fully or nearly completed 
migration into their mature location within the neural retina.
As development proceeded, a rapid increase in the 
number of phosducin-expressing cells occurred between 
E12.3 and E13.5 (compare Figure 1C,D). As might be 
expected from the central to peripheral gradient of retinal 
differentiation [38], no phosducin-positive cells were 
found in the distal retina at this age. From E13.5 to E15.5, a 
gradual increase in the number of phosducin-reactive cells 
was observed, with the further progression of stained cells 
toward the distal retina. By E17.5, the number of phosducin-
positive cells increased, and this trend continued through 
the last stage tested, P21 (Figure 1F–I). To demonstrate that 
the staining observed in these images accurately represents 
the expression of phosducin protein, retinal sections from 
a phosducin knockout mouse line [28] were processed and 
reacted with anti-phosducin antibody. No reactivity was 
observed anywhere within the phosducin-knockout retinas 
at either E13.5 (Figure 2A) or P0 (Figure 2B), demonstrating 
that the antibody showed no cross-reactivity in the retina at 
embryonic or neonatal ages. For positive controls, phosducin-
knockout retinas and similarly aged controls were colabeled 
with anti-phosducin and either anti-Otx2 at E13.5 or anti-cone 
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transducin γ at P0. Expression of Otx2 (Figure 2A) and cone 
transducin γ (Figure 2B) was observed in the control and 
phosducin-knockout retinas, whereas phosducin expression 
was lacking in the phosducin-knockout retinal sections.
Colocalization of phosducin and photoreceptor markers: 
Examination of the coexpression of phosducin with a 
known photoreceptor marker, orthodenticle homeobox 2 
protein (Otx2), and a known cone-specific marker, retinoid 
X receptor gamma (Rxrγ), was performed to determine the 
cellular specificity of phosducin labeling in the embryonic 
retina. Otx2 is important for cell fate determination of 
photoreceptors and is expressed in photoreceptors and the 
Figure 1. Developmental expression of phosducin protein in the embryonic and postnatal retina. Immunohistochemical staining was 
performed on coronal sections starting at (A) E10.5 (before cone birth) through (I) P21. Anti-phosducin antibody labeled photoreceptors 
starting at E12.5 (arrows in C) and continued through all time points tested. Arrowhead indicates the RPE. Scale bars = 100 µm.
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RPE until P6 [15]. Expression of Otx2 is seen in migrating 
and post-migratory developing photoreceptors. We used 
immunof luorescence to determine whether phosducin 
and Otx2 are expressed in the same cells. Both proteins 
localized to the ventricular surface with a large amount of 
colocalization (Figure 3A). Phosducin-positive cells almost 
always expressed Otx2; however, not all Otx2-positive cells 
expressed phosducin. Otx2 was expressed prominently in 
migrating (arrows in Figure 3A) photoreceptor precursors and 
post-migratory photoreceptor cells. Thus, these expression 
Figure 2. Comparison of PdcKO and control retinas. Immunofluorescence was performed on coronal sections of control and phosducin 
knockout (PdcKO) mice at ages E13.5 (A) using anti-Pdc and anti-Otx2 antibodies and P0 (B) using anti-Pdc and anti-cone transducin γ 
(Gngt2) antibodies. Pdc expression is seen in the control retinas and is absent in the PdcKO retinas, whereas Otx2 and Gngt2 are expressed 
in the control and PdcKO retinas. Scale bars = 100 µm.
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patterns supported the supposition that phosducin labels post-
migratory photoreceptors during embryonic ages.
Rxrγ is involved in the formation of the S-opsin gradient 
of cone photoreceptors and is expressed in the embryonic 
neural retina in postmitotic cones and retinal ganglion cells 
with peak expression at E17.5 [20,39]. To examine the cellular 
specificity of phosducin expression in developing cones, we 
performed immunofluorescence with anti-phosducin and 
anti-Rxrγ antibodies in E17.5 retinal sections. Both proteins 
were expressed along the ventricular border of the retina 
and colocalized (Figure 3B), suggesting that the majority of 
phosducin-labeled cells in the embryonic retina, up to and 
including E17.5, were cones.
Expression of cone transducin γ in the developing mouse 
retina: Because phosducin is known to interact with trans-
ducin βγ and cone transducin γ is expressed embryonically 
[21], we sought to determine the earliest age at which cone 
transducin γ could be detected. Similar to the results seen 
for phosducin expression, cone transducin γ was expressed 
in the outer neuroblastic layer of the embryonic mouse 
retina (Figure 4). Cone transducin γ protein could not be 
detected through E12.5 (Figure 4A–C) but was detected 
at E13.5 (Figure 4D). As with phosducin expression, cone 
transducin γ-immunoreactive cells were observed only along 
the ventricular edge of the retina. The expression timing and 
limited expression domain suggested that cone transducin γ 
may be expressed in differentiated cones only once they have 
fully migrated into position, similar to phosducin. Expression 
continued to expand from the central retina into the periphery 
over the course of embryonic retinal development (Figure 
4D–F), similar to the pattern seen with phosducin expression 
(Figure 1). Unlike the expression pattern of phosducin, the 
cone transducin γ-reactive cell numbers appeared to remain 
Figure 3. Colocalization of phosducin with known photoreceptor markers in the embryonic retina. A: Fluorescent imaging of coronal sections 
of mouse retinas at E15.5 shows the colocalization of phosducin and Otx2, a photoreceptor marker, along the ventricular surface. Otx2 shows 
RPE labeling (arrowheads) in addition to photoreceptor labeling. Otx2-positive, Pdc-negative migrating cells are also seen interior to the 
ventricular surface (arrows). B: Immunofluorescent imaging of the retinal sections at E17.5 for phosducin and the cone marker, Rxrγ, shows 
consistent colocalization along the ventricular surface of the retina. Scale bars = 50 µm.
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constant from E17.5 to P21 (Figure 4F–I), consistent with the 
findings that 95% of cones are born by the day of birth [2,3].
Colocalization of phosducin and cone transducin γ protein 
expression: Given the similar embryonic localization patterns 
seen between phosducin and cone transducin γ, we used 
immunofluorescence to determine whether these two proteins 
colocalize in retinal cells. Examination of the expression of 
both proteins from E13.5 to P8 (Figure 5A–E) showed they 
were distributed widely across the retina along the central to 
peripheral axis but were restricted to the ventricular layer. 
Prominent colocalization of phosducin and cone transducin 
γ was seen in coronal eye sections at all ages examined. 
Figure 4. Developmental expression of cone transducin γ protein in the embryonic and postnatal retina. Immunohistochemical staining was 
performed on coronal sections starting at (A) E10.5 (before cone birth) through (I) P21. Beginning at E13.5, cone transducin γ expression 
is observed in cells along the ventricular surface (arrows in D), and this expression continues through all ages tested. Scale bars = 100 µm.
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Using E13.5–P0 retinal sections, we quantified the amount 
of coexpression by determining the percentage of cells that 
were labeled with phosducin only, cone transducin γ only, 
and those colabeled with phosducin and cone transducin γ. 
At E13.5, 97% (±0.4%; SD) of the labeled cells in the retina 
were colabeled. The percentage of colabeled cells dropped at 
E15.5 and E17.5 to 88% (±1.1%; SD) and 87% (±2.4%; SD), 
respectively, and by P0, the percentage of colabeled cells was 
79% (±6.2%; SD; Figure 5F). This quantification of colocal-
ization suggests that most phosducin-labeled cells are cones 
at most embryonic ages, although rod histogenesis has begun 
by this time [2,3].
Phosducin and cone transducin γ mRNA expression levels 
show different dynamics: After early detection of phosducin 
and cone transducin γ expression in the developing mouse 
retina with immunohistochemistry (E12.5; Figure 1C and 
E13.5; Figure 4D), we sought to explore phosducin and cone 
transducin γ gene expression. We analyzed mRNA expression 
levels for phosducin (Pdc) and cone transducin γ (Gngt2) by 
qPCR, using gene-specific primer sets. Samples were tested 
from littermates used for the immunolocalization presented 
above for consistency. A minimum of three biologic replicates 
were analyzed and averaged for each age. Pdc expression 
above the threshold was detected at E10.5 and E11.5, but these 
levels were only 0.4% and 0.2% that of P0 levels, respectively 
(Figure 6A). The extremely low expression levels and relative 
decrease from E10.5 to E11.5 suggest that these values may 
reflect the sporadic phosducin-positive protein staining seen 
Figure 5. Colocalization of phosducin and cone transducin γ expression in the retina. Fluorescent imaging of coronal sections of mouse 
retina from E13.5-P8 (A–E) was performed using anti-phosducin and anti-cone transducin γ antibodies. Both markers localized almost 
exclusively to the ventricular surface at all ages tested. Scale bars = 50 µm. Quantification of the colabeled cell for ages E13.5–P0 (F) shows 
a high percentage of colabeled cells (97% ±0.4%; SD) at E13.5 that progressively decreased with age (E15.5 was 88% ±1.1%; E17.5 was 87% 
± 2.3%; P0 was 79% ±6.2%). Phosducin-only cells comprised 2.4% ±1.1% at E13.5, 11.3% ±1.3%, at E15.5, 12.3% ±2.2% at E17.5, and 20% 
±6.6% at P0. Cone transducin γ–only cells constituted 0.8% ±0.7% at E13.5, 1% ±0.04% at E15.5, 1% ±0.4% at E17.5, and 1.2% ±0.7% at P0. 
The blue bars indicate cells that are colabeled, the phosducin-only cells are shown in red, the cone transducin γ–only cells appear in green, 
and the error bars represent standard deviations.
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at E12.5, and that decreases between E10.5 and E11.5 could 
represent stochastic variations in small numbers. No values 
above the threshold were detected in samples from either the 
E13.5 or P0 phosducin-knockout animals, suggesting that 
other cellular RNAs do not contribute a background signal 
and that these extremely low levels of phosducin expression 
at E10.5 and E11.5 may represent real expression.
The relative Pdc expression levels increased dramatically 
at E12.5, with levels six-fold higher than at E11.5 and approxi-
mately 1.3% those of P0 samples (Figure 6A). Given that the 
phosducin protein is first detected at this stage, this would 
seem to be a minimum age at which Pdc expression can reli-
ably be demonstrated, but earlier expression is certainly a 
distinct possibility. Dramatic increases in Pdc mRNA levels 
were observed between E13.5 (3.7% of P0 levels) and E15.5 
(19.7% of P0 levels). Although the E17.5 levels for Pdc were 
roughly one-third those of P0, the levels at P8 were more than 
nine-fold greater than the P0 levels. This large increase in 
postnatal phosducin levels is consistent with the increase seen 
in phosducin protein expression and could reflect the fact 
that rod photoreceptors are primarily formed during postnatal 
stages of mouse development [2,38] and rods represent about 
97% of the photoreceptors in the mouse retina [2,40].
As with Pdc gene activation, expression of Gngt2 mRNA 
was detected at E10.5 with qPCR, with levels at 1.4% of those 
values at P0 (Figure 6B). A similar decrease was observed 
for Pdc and Gngt2 from E10.5 to E11.5, with levels jumping 
up 2.6-fold by E12.5. A steady increase in Gngt2 expression 
occurred from E12.5 to P0. However, unlike the situation with 
Pdc in which a large increase in mRNA expression occurred 
between P0 and P8, the relative Gngt2 levels at P8 decreased 
to 61.5% of those seen at P0. This decrease potentially reflects 
Figure 6. mRNA expression across developmental ages measured with qPCR. A: Pdc expression above the threshold was detected with 
qPCR at E10.5 and E11.5 but at extremely low levels. The relative Pdc expression levels increase at E12.5, which is consistent with protein 
expression (see Figure 1). Expression increases gradually through P0, and then at P8, there is a dramatic increase in the Pdc mRNA levels. 
B: Expression of Gngt2 mRNA is detected with qPCR at E10.5 and E11.5, but similar to phosducin, at low levels. A steady increase in Gngt2 
expression occurs from E12.5 to P0. The Gngt2 levels at P8 decrease slightly relative to the P0 values. All numbers are expressed relative 
to P0 and normalized to the Hprt levels in each sample and graphed on a log scale. At each age, three independent samples were collected, 
and each of these samples was run in triplicate as technical replicates. Red lines indicate the average for that age group; black circles are 
individual samples at each age group.
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the overall dilution of cone photoreceptor cell contribution 
to the total RNA pool with the rapid growth of the retina 
during the postnatal time period and the paucity of new cone 
histogenesis that takes place postnatally.
DISCUSSION
Embryonic photoreceptor-specific expression for visual 
transduction proteins: We present evidence that proteins 
important for phototransduction are expressed early in 
embryonic photoreceptors. We show the onset of phosducin 
protein expression at E12.5, which precedes earlier reports by 
nearly 2 weeks (E12.5 versus P5 [27,35]), and cone transducin 
γ protein expression at E13.5, preceding the earliest reported 
detection by 2 days [21]. Expression of both proteins was 
nearly 3 weeks before the onset of M-opsin protein expression 
at P14 and nearly 1 week before S-opsin protein expression 
at P0 [5,9].
We infer that the embryonic expression of phosducin and 
cone transducin γ is labeling cone photoreceptors. Several 
lines of evidence support this inference. First, in the postnatal 
retina, cone transducin γ is specific for cones, and phosducin 
is specific for photoreceptors [24,41]. Second, cone transducin 
γ- and phosducin-positive cells reside along the ventricular 
border, the location of photoreceptors. Additionally, immuno-
fluorescence showed phosducin and cone transducin γ to be 
coexpressed in cells. Given the regionalized expression and 
colocalization of these proteins, these findings suggest that 
cone transducin γ and phosducin are expressed in photorecep-
tors that have migrated into their adult location, similar to the 
expression pattern seen for early photoreceptor markers, Crx 
[12,42] and Trβ2 [11,18]. Third, colocalization of phosducin 
with Otx2 and Rxrγ, known markers for photoreceptors and 
cones, respectively, suggests cone-specific labeling of phos-
ducin at embryonic ages. Quantification of colocalization 
data suggests that, at E13.5, virtually all of phosducin-labeled 
cells are cones, and by E17.5, most labeled cells (87%) are still 
cones, as they are phosducin- and cone transducin γ–positive.
Rapid increases in phosducin, but not cone transducin γ, in 
the postnatal retina: From P0 to P8, we observed a nine-fold 
increase in Pdc mRNA expression with qPCR. This increase 
likely reflects the massive production of rod photoreceptors 
that occurs during early postnatal development, such that 
50% of all retinal cells and 97% of all mouse photoreceptors 
are rods [2,40]. The possibility also exists that, in addition to 
a dramatic increase in rod cell numbers during this period, 
the expression levels of phosducin within each photoreceptor 
could be increasing. With this caveat in mind, however, the 
magnitude of change for phosducin expression was consistent 
with the increase in rod cell number during early postnatal 
retinal development [3].
Potential functions for visual transduction proteins in the 
embryonic retina: Surprisingly, the temporal pattern of 
phosducin and cone transducin γ was coincident with the 
expression of early cone-determining transcription factors, 
suggesting that photoreceptor precursor cells are fully 
committed to a cone differentiation pattern at these early 
ages. Since the phototransduction process is weeks removed 
from this expression, these visual transduction factors likely 
play other functional roles in the embryonic photoreceptor 
cell. We observed an absence of other visual transduction 
proteins (mouse cone arrestin, cone phosphodiesterase and 
S-cone opsin) in the mouse retina at E15.5. Although visual 
transduction proteins have been found embryonically in the 
primate retina [43,44], this expression is at a stage of develop-
ment that matches the postnatal period in rodents, suggesting 
that cone transducin γ and phosducin may have specific func-
tions in the embryonic retina unrelated to their roles in visual 
transduction.
As a result, we sought clues in the literature to identify 
potential activity of cone transducin γ and phosducin in the 
embryonic mouse retina, if any. Previous studies on phos-
ducin show that it can interact with Crx in cultured cells, 
where phosducin acts to inhibit Crx-mediated transcription 
at the interphotoreceptor retinoid-binding protein (IRBP) 
promoter [45]. In addition, phosducin possesses a transcrip-
tional activation domain at the C-terminal end [46], although 
this would appear to conflict with the reported repression 
of Crx transcriptional activity [45]. Previous studies have 
yielded conflicting information regarding the localization of 
phosducin. Whereas Zhu et al. [45] demonstrated that phos-
ducin colocalized to the nucleus when coexpressed with Crx 
in Cos7 cells and in the adult bovine retina (where phosducin 
shows nuclear and cytoplasmic localization), the same group 
[46] and others [47,48] found phosducin to be cytoplasmic. If 
phosducin localized to the nucleus, this finding would suggest 
a possible role in transcription; however, the cytoplasmic 
localization seen in our study would suggest that perhaps 
there is an additional function for embryonic phosducin 
beyond any transcriptional activities.
Another possible function for embryonic phosducin 
expression is that phosducin may interact with cone trans-
ducin βγ as phosducin does postnatally [49]. This possibility 
would lead to the obvious question regarding the potential 
function for G protein βγ at embryonic ages. Although the 
transducin βγ complex is known to function only in photo-
transduction, the function of the transducin βγ complex 
during embryonic stages has not been explored to our 
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knowledge. Given the large number of G protein-coupled 
receptors (GPCRs) and their expression in multiple tissues 
and cell types, it is conceivable that the transducin βγ 
complex has additional functions during embryonic retinal 
development that have yet to be fully understood or explored. 
Some potential GPCR signaling pathways involved in retinal 
function include dopamine signaling [50,51], hedgehog (Hh) 
signaling [52,53], and Wnt signaling [54], along with others 
[55,56]. Wnt signaling in the retina appears to function 
primarily in the RPE at embryonic ages [54], and therefore is 
unlikely to involve phosducin and cone transducin γ activity 
in photoreceptor cell differentiation. Dopamine signaling 
appears to occur at later embryonic and postnatal stages 
than seen for the earliest phosducin and cone transducin γ 
expression [51]. Hh signaling plays a significant role in retinal 
progenitor cell proliferation [57], and factors induced by Hh 
signaling (e.g., Gli1) overlap spatially and temporally with 
the expression for phosducin shown above [58]. However, 
functional manipulation of Hh signaling [58-60] suggests that 
it either antagonizes cone photoreceptor specification or has a 
transient role in cone differentiation. Therefore, further work 
is necessary to elucidate the early functions for phosducin and 
cone transducin γ in the developing retina and their potential 
roles in photoreceptor cell differentiation.
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